This topic contains a solution. Click here to go to the answer

Author Question: Social insurance programs differ from welfare programs in that social insurance programs are not ... (Read 60 times)

Brittanyd9008

  • Hero Member
  • *****
  • Posts: 500
Social insurance programs differ from welfare programs in that social insurance programs are not subject to
 
  a. employment requirements.
  b. age limits.
  c. racial and ethnic recipient quotas.
  d. means testing.
  e. citizenship verification.

Question 2

Under which U. S. President did the political philosophy of greater political participation by ordinary citizens spread throughout the country?
 
  a. Thomas Jefferson
  b. Andrew Jackson
  c. Abraham Lincoln
  d. Teddy Roosevelt



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

kardosa007

  • Sr. Member
  • ****
  • Posts: 300
Answer to Question 1

D

Answer to Question 2

b




Brittanyd9008

  • Member
  • Posts: 500
Reply 2 on: Jul 8, 2018
Thanks for the timely response, appreciate it


patma1981

  • Member
  • Posts: 292
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

If you could remove all of your skin, it would weigh up to 5 pounds.

Did you know?

Atropine was named after the Greek goddess Atropos, the oldest and ugliest of the three sisters known as the Fates, who controlled the destiny of men.

Did you know?

The human body's pharmacokinetics are quite varied. Our hair holds onto drugs longer than our urine, blood, or saliva. For example, alcohol can be detected in the hair for up to 90 days after it was consumed. The same is true for marijuana, cocaine, ecstasy, heroin, methamphetamine, and nicotine.

Did you know?

Despite claims by manufacturers, the supplement known as Ginkgo biloba was shown in a study of more than 3,000 participants to be ineffective in reducing development of dementia and Alzheimer’s disease in older people.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library